Tempus AI’s TEM stock has surged nearly 13% since its second-quarter 2025 earnings release. The quarter saw strong top-line ...

Tempus AI (TEM) has posted an impressive price move of 21% over the last week, likely influenced by a blend of recent developments. The company announced significant revenue growth in its second ...

Tempus AI TEM stock saw a positive improvement to its Relative Strength (RS) Rating on Thursday, rising from 66 to 78. Please ...

After Tempus AI’s Q2 earnings release, analysts at Morgan Stanley increased their price target on the stock from $65 to $68.

Tempus AI, Inc. TEM is rapidly expanding its partnerships across oncology and neuroscience, leveraging its AI platforms — Lens and Next — to accelerate precision medicine. Tempus has entered into a ...

On fundamentals, Medtronic’s current market capitalization is $119 billion. Over the last twelve months, the company ...

Ark Invest has six main ETFs with several around for more than 10 years. A look at the top 10 holdings across the six funds ...

Cathie Wood’s ARK ETFs have reported their daily trades for Tuesday, August 19th, 2025, with significant activity across a range of stocks. Leading the purchases was Robinhood Markets Inc (NASDAQ: ...

Dan Ives' AI Revolution ETF (IVES) is heavily weighted toward big tech, betting these giants will lead the AI boom. Click ...

Uncertainty returned to the market this week after conflicting news on inflation in July. Consumer prices matched expectations, but producer prices were sharply higher. For now, investors are ignoring ...

Tempus AI, a stock tied to former House Speaker Nancy Pelosi, is facing fresh skepticism on Wall Street despite its strong ...